2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

ASCO 2020 CLL Updates: Should Everyone Get Ibrutinib?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Manali Kamdar
By 2020 ASCO Virtual Direct™ Highlights FEATURING Manali Kamdar
456 views
August 24, 2020
Comments 4
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh
Hematologic Oncology
20:35

ASCO 2020 CLL Updates: Should Everyone Get Ibrutinib?

2020 ASCO Virtual Direct™ Highlights

M. Kamdar

456 views
12:40

2020 ASCO Updates on DLBCL: What Is the Optimal Venetoclax Dosing w/…

2020 ASCO Virtual Direct™ Highlights

M. Kamdar

121 views
04:47

2020 ASCO Update on Indolent Lymphoma: Obinutuzumab + Chemo vs. Ritu…

2020 ASCO Virtual Direct™ Highlights

M. Kamdar

210 views
04:36

2020 ASCO Update on Hodgkin Lymphoma: Is Pembrolizumab a Better Opti…

2020 ASCO Virtual Direct™ Highlights

M. Kamdar

27 views